Hydrolyzed collagen for use in reducing blood glucose
AssigneeRousselot B.V.
InventorsKristof Robert Callemin, Elien Monique Gevaert, Arne Goes, Janne Prawitt, Sara Vleminckx
Life of this patent
Estimating the term…
Abstract
The present invention relates to a hydrolyzed collagen formulation for use in decreasing blood glucose. The hydrolyzed collagen is obtained by enzymatic hydrolysis of a collagen-containing material with a combination of enzymes comprising two or more enzymes selected from the group consisting of a neutral protease, a carboxypeptidase, and an aminopeptidase. The hydrolyzed collagen formulation is particularly suitable as a food supplement, such as for use in ameliorating hyperglycemia and/or a risk factor hyperglycemia.
Claims9
A method for lowering blood glucose level in a human subject in need thereof, comprising administering a hydrolyzed collagen to the human subject, wherein the hydrolyzed collagen is obtained by enzymatic hydrolysis of a collagen-containing material with a combination of enzymes comprising a neutral protease and one or both of a carboxypeptidase, and an aminopeptidase,
- wherein the hydrolyzed collagen is administered in an effective amount as one or more unit doses of at least 0.5 g per day and wherein the total daily dose is not more than 30 g, wherein the amount is the dry weight amount.
Dependencies are inferred from the claim text.